Cervical Cancer Screening and Updated Pap Guidelines

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide. Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. Screening via Papanicolaou testing is critical, and interpretation of test results with knowledge of patient risk factors is imperative. Many evidence-based guidelines for screening, interpretation, and management have been developed and are widely available for use.

Original languageEnglish (US)
Pages (from-to)131-149
Number of pages19
JournalPrimary Care - Clinics in Office Practice
Issue number1
StatePublished - Mar 2009


  • Abnormal pap
  • Cervical cancer
  • Dysplasia
  • Guidelines
  • HPV
  • Pap testing
  • Screening

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Cervical Cancer Screening and Updated Pap Guidelines'. Together they form a unique fingerprint.

Cite this